Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yocheved Gilad

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Journal of Chemical Information and Modeling|December 6, 2013
Docking studies on DNA intercalatorsYocheved Gilad, Hanoch Senderowitz
Journal of Cheminformatics|December 23, 2015
A reliable computational workflow for the selection of optimal screening librariesYocheved Gilad, Katalin Nadassy, Hanoch Senderowitz
Frontiers in Molecular Neuroscience|October 4, 2018
Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM LeukodystrophyAndrea Atzmon, Melisa Herrero, Reut Sharet-Eshed, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Journal of Chemical Information and Modeling|December 6, 2013
Docking studies on DNA intercalatorsYocheved Gilad, Hanoch Senderowitz
Journal of Cheminformatics|December 23, 2015
A reliable computational workflow for the selection of optimal screening librariesYocheved Gilad, Katalin Nadassy, Hanoch Senderowitz
Frontiers in Molecular Neuroscience|October 4, 2018
Drug Screening Identifies Sigma-1-Receptor as a Target for the Therapy of VWM LeukodystrophyAndrea Atzmon, Melisa Herrero, Reut Sharet-Eshed, et al.
Journal of Medicinal Chemistry|May 22, 2014
Highly potent and selective ectonucleotide pyrophosphatase/phosphodiesterase I inhibitors based on an adenosine 5'-(α or γ)-thio-(α,β- or β,γ)-methylenetriphosphate scaffoldYael Nadel, Joanna Lecka, Yocheved Gilad, et al.
Pageof 1